Comprehensive Analysis of Survival Outcomes in Non–Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference39 articles.
1. 2004 WHO classification of the renal tumors of the adults;Lopez-Beltran;Eur Urol,2006
2. The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours;Moch;Eur Urol,2016
3. Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria;Kroeger;Cancer,2013
4. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007
5. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors;Motzer;Cancer,2010
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma;Journal for ImmunoTherapy of Cancer;2023-11
2. Increased Level of Serum Leucine-Rich-Alpha-2-Glycoprotein 1 in Patients with Clear Cell Renal Cell Carcinoma;2023-08-23
3. SEOM SOGUG clinical guideline for treatment of kidney cancer (2022);Clinical and Translational Oncology;2023-08-09
4. The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma;Cancers;2023-07-29
5. Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC;Nature Reviews Urology;2023-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3